Cite
HARVARD Citation
Hwang, J. et al. (2017). Impact of the timing of hepatitis B virus identification and anti–hepatitis B virus therapy initiation on the risk of adverse liver outcomes for patients receiving cancer therapy. Cancer. 123 (17), pp. 3367-3376. [Online].